Press question mark to see available shortcut keys
Home
Collections
Join Google+
Send Feedback
Help
Region
Privacy Policy
-
Terms of Service
-
Maps Terms
©2017 Google
Search
Sign in
The Oncologist
Public
May 3, 2017
FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma
theoncologist.alphamedpress.org
no plus ones
no comments
no shares
Shared publicly
